DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Hold" from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) has been given an average rating of "Hold" by the thirteen brokerages that are currently covering the company, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $20.36.

XRAY has been the subject of several recent research reports. Mizuho decreased their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Piper Sandler cut their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Barrington Research upped their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock worth $309,864,000 after acquiring an additional 557,329 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock valued at $208,590,000 after purchasing an additional 1,412,517 shares during the last quarter. Nuance Investments LLC boosted its stake in DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in DENTSPLY SIRONA by 4.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier's stock worth $180,445,000 after acquiring an additional 538,531 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $15.94 on Monday. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $27.95. The firm has a fifty day moving average of $14.60 and a two-hundred day moving average of $16.94. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.18 billion, a P/E ratio of -7.70, a P/E/G ratio of 1.80 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. During the same period last year, the firm posted $0.42 EPS. DENTSPLY SIRONA's quarterly revenue was down 7.8% compared to the same quarter last year. As a group, research analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.02%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.